Immune responses of NIH mice infected with avirulent and virulent strains of Plasmodium chabaudi adami single and mixed infections

Korean Journal of Parasitology

Volumn 48, Issue 1, 2010, Pages 23-33

  Namazi, M J ^a   Phillips, R S ^b  

^a SABZEVAR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cytokine; Immune response; NIH mouse; Plasmodium chabaudi adami; Single and mixed infection; Th1 Th2

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMORAL IMMUNITY; MIXED INFECTION; MOUSE; NONHUMAN; PARASITE VIRULENCE; PARASITEMIA; PLASMODIUM CHABAUDI; PLASMODIUM CHABAUDI INFECTION; SPLEEN CELL; STRAIN DIFFERENCE; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, PROTOZOAN; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALARIA; MICE; PLASMODIUM CHABAUDI; TH1 CELLS; TH2 CELLS;

MUS; PLASMODIUM CHABAUDI ADAMI;

EID: 77949719113     PISSN: 00234001     EISSN: 17380006     Source Type: Journal    
DOI: 10.3347/kjp.2010.48.1.23     Document Type: Article

References (53)

1. WHO. Malaria. http://www.who.int/mediacentre/factsheets/fs094/en/index. html. 2010.
2. Wipasa J, Elliott S, Xu H, Good MF. Immunity to asexual blood stage malaria and vaccine approaches. Immunol Cell Biol 2002; 80: 401-414.
3. Babiker HA, Creasey AM, Bayoumi RA, Walliker D, Arnot DE. Genetic diversity of Plasmodium falciparum in a village in eastern Sudan. 1. Diversity of enzymes, 2D-PAGE proteins and antigens. Trans R Soc Trop Med Hyg 1991; 85: 572-577.
4. Taylor-Robinson AW. Regulation of immunity to malaria: valuable lessons learned from murine models. Parasitol Today 1995; 11: 334-341.
5. Langhorne J. The role of CD4(+) T-cells in the immune response to Plasmodium chabaudi. Parasitol Today 1989; 5: 362-364.
6. Smith EC, Taylor-Robinson AW. Parasite-specific immunoglobulin isotypes during lethal and non-lethal murine malaria infections. Parasitol Res 2003; 89: 26-33.
7. McDonald V, Phillips RS. Plasmodium chabaudi: Adoptive transfer of immunity with different spleen cell populations and development of protective activity in the serum of lethally irradiated recipient mice. Exp Parasitol 1980; 49: 26-33.
8. De Souza JB, Ling IT, Ogun SA, Holder AA, Playfair JH. Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant. Infect Immun 1996; 64: 3532-3536.
9. Jacobs P, Radzioch D, Stevenson MM. Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice. J Immunol 1995; 155: 5306-5313.
10. Sam H, Stevenson MM. Early IL-12 p70, but not p40, production by splenic macrophages correlates with host resistance to bloodstage Plasmodium chabaudi AS malaria. Clin Exp Immunol 1999; 117: 343-349.
11. Stavnezer J. Antibody class switching. Adv Immunol 1996; 61: 79-146.
12. Ockenhouse CF, Shear HL. Oxidative killing of the intraerythrocytic malaria parasite Plasmodium yoelii by activated macrophages. J Immunol 1984; 132: 424-431.
13. Su Z, Stevenson MM. Central role of endogenous gamma interferon in protective immunity against blood-stage Plasmodium chabaudi AS infection. Infect Immun 2000; 68: 4399-4406.
14. Yoneto T, Waki S, Takai T, Tagawa Yi, Iwakura Y, Mizuguchi J, Nariuchi H, Yoshimoto T. A critical role of Fc receptor-mediated antibody-dependent phagocytosis in the host resistance to bloodstage Plasmodium berghei XAT infection. J Immunol 2001; 166: 6236-6241.
15. Balmer P, Alexander J, Phillips RS. Protective immunity to erythrocytic Plasmodium chabaudi AS infection involves IFN-gammamediated responses and a cellular infiltrate to the liver. Parasitology 2000; 121: 73-82.
16. Taylor-Robinson AW, Phillips RS. Th1 and Th2 CD4+ T cell clones specific for Plasmodium chabaudi but not for an unrelated antigen protect against blood stage P. chabaudi infection. Eur J Immunol 1994; 24: 158-164.
17. Taylor-Robinson AW, Smith EC. Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway. Immunology 1999; 96: 498-504.
18. Langhorne J, Quin SJ, Sanni LA. Mouse models of blood-stage malaria infections: immune responses and cytokines involved in protection and pathology. Chem Immunol 2002; 80: 204-228.
19. Weidanz WP, Kemp JR, Batchelder JM, Cigel FK, Sandor M, Heyde HC. Plasticity of immune responses suppressing parasitemia during acute Plasmodium chabaudi malaria. J Immunol 1999; 162: 7383-7388.
20. Rainczuk A, Scorza T, Smooker PM, Spithill TW. Induction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors. Infect Immun 2003; 71: 4506-4515.
21. Anders RF, Crewther PES, Edwards M, Margetts M, Matthew ML, Pollock B, Pye D. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine 1998; 16: 240-247.
22. Smooker PM, Setiady YY, Rainczuk A, Spithill TW. Expression library immunization protects mice against a challenge with virulent rodent malaria. Vaccine 2000; 18: 2533-2540.
23. Black J, Hommel M, Snounou G, Pinder M. Mixed infections with Plasmodium falciparum and P. malariae and fever in malaria. Lancet 1994; 343: 1095.
24. Taylor LH, Walliker D, Read AF. Mixed-genotype infections of the rodent malaria Plasmodium chabaudi are more infectious to mosquitoes than single-genotype infections. Parasitology 1997; 115: 121-132.
25. Snounou G, Bourne T, Jarra W, Viriyakosol S, Wood JC, Brown KN. Assessment of parasite population dynamics in mixed infections of rodent plasmodia. Parasitology 1992; 105: 363-374.
26. Maitland K, Williams TN, Newbold CI. Plasmodium vivax and P. falciparum: biological interactions and the possibility of cross-species immunity. Parasitol Today 1997; 13: 227-231.
27. Cox FE, Voller A. Cross-immunity between the malaria parasites of rodents. Ann Trop Med Parasitol 1966; 60: 297-303.
28. McColm AA, Dalton L. Heterologous immunity in rodent malaria: comparison of the degree of cross-immunity generated by vaccination with that produced by exposure to live infection. Ann Trop Med Parasitol 1983; 77: 355-377.
29. Jarra W, Brown KN. Protective immunity to malaria: Studies with cloned lines of Plasmodium chabaudi and P. berghei in CBA/Ca mice. I. The effectiveness and inter- and intra-species specificity of immunity induced by infection. Parasite Immunol 1985; 7: 595-606.
30. Jarra,W, Brown KN. Protective immunity to malaria: Studies with cloned lines of rodent malaria in CBA/Ca mice. IV. The specificity of mechanisms resulting in crisis and resolution of the primary acute phase parasitaemia of Plasmodium chabaudi chabaudi and P. yoelii yoelii. Parasite Immunol 1989; 11: 1-13.
31. Brown KN. The parasitology of malaria and the study of protective immunity. Immunol Lett 1990; 25: 97-99.
32. Bruce MC, Donnelly CA, Alpers MP, Galinski MR, Barnwell JW, Walliker D, Day KP. Cross-species interactions between malaria parasites in humans. Science 2000; 287: 845-848.
33. Daneshvar H, Hagan P, Phillips RS. Leishmania mexicana H-line attenuated under pressure of gentamicin, potentiates a Th1 response and control of cutaneous leishmaniasis in BALB/c mice. Parasite Immunol 2003; 25: 589-596.
34. McDonald V, Sherman IW. Plasmodium chabaudi: Humoral and cell-mediated responses of immunized mice. Exp Parasitol 1980; 49: 442-454.
35. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science 1976; 193: 673-675.
36. Cox FE. Acquired immunity to Plasmodium vinckei in mice. Parasitology 1966; 56: 719-732.
37. Glynn J R. Infecting dose and severity of malaria: a literature review of induced malaria. J Trop Med Hyg 1994; 97: 300-316.
38. Timms RN, Colegrave B, Chan H, Read AF. The effect of parasite dose on disease severity in the rodent malaria Plasmodium chabaudi. Parasitology 2001; 123: 1-11.
39. Taylor-Robinson AW, Phillips RS. Infective dose modulates the balance between Th1- and Th2-regulated immune responses during blood-stage malaria infection. Scand J Immunol 1998; 48: 527-534.
40. Marsh K. Malaria: a neglected disease? Parasitology 1992; 104: S53-S69.
41. De Souza JB, Williamson KH, Otani T, Playfair JH. Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria. Infect Immun 1997; 65: 1593-1598.
42. Podoba JE, Stevenson MM. CD4+ and CD8+ T lymphocytes both contribute to acquired immunity to blood-stage Plasmodium chabaudi AS. Infect Immun 1991; 59: 51-58.
43. Taylor-Robinson AW, Phillips RS, Severn A, Moncada S, Liew FY. The role of TH1 and TH2 cells in a rodent malaria infection. Science 1993; 260: 1931-1934.
44. Kima PE, Srivastava IK, Long CA. Proteins with molecular masses of 25 to 40 kilodaltons elicit optimal protective responses against Plasmodium chabaudi adami infection. Infect Immun 1992; 60: 5065-5070.
45. Stevenson MM, Tam MF. Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice. Clin Exp Immunol 1993; 92: 77-83.
46. Saul A. Models for the in-host dynamics of malaria revisited: errors in some basic models lead to large over-estimates of growth rates. Parasitology 1998; 117: 405-407.
47. Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annl Rev Immunol 1994; 12: 635-673.
48. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787-793.
49. von der Weid TM, Kopf, Kohler G, Langhorne J. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur J Immunol 1994; 24: 2285-2293.
50. van der Heyde HC, Pepper B, Batchelder J, Cigel F, Weidanz WP. The time course of selected malarial infections in cytokine-deficient mice. Exp Parasitol 1997; 85: 206-213.
51. Couper KN, Blount DG, Wilson MS, Hafalla JC, Belkaid Y, Kamanaka M, Flavell RA, de Souza JB, Riley EM. IL-10 from CD4+ CD25-Foxp3-CD127- adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog 2008; 4: e1000004.
52. Kelly MN, Kolls JK, Happel K, Schwartzman JD, Schwarzenberger P, Combe C, Moretto M, Khan IA. Interleukin-17/interleukin-17 receptor-mediated signalling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun 2005; 73: 617-621.
53. Rutitzky LI, Lopes da Rosa JR, Stadecker MJ. Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J Immunol 2005; 175: 3920-3926.